Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Trial of Loncastuximab Tesirine in High Risk Diffuse Large B-cell Lymphoma Post Transplant
ClinicalTrials.gov study NCT05222438. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HBV-Specific TCR-T Cell Therapy Combined With Nucleos(t)Ide Analogues in Chronic Hepatitis B Patients
ClinicalTrials.gov study NCT06885710. IPD Sharing: Not stated. Countries: 1. Publications: 0.
VELCADE® (Bortezomib) With Rituximab in Subjects With Relapsed or Refractory Indolent B-Cell Lymphoma
ClinicalTrials.gov study NCT00085696. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of Forodesine in Patients With Relapsed B-cell Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00646165. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Early On-therapy PET at First-line Treatment in Diffuse Large B-cell Lymphoma Stage IIB-IV
ClinicalTrials.gov study NCT00286832. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Follow-up Study of CD19 CAR-T Expressing IL7 and CCL19 for Relapsed or Refractory B Cell Lymphoma
ClinicalTrials.gov study NCT04833504. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Safety Study of SGN-CD19A for B-Cell Lymphoma
ClinicalTrials.gov study NCT01786135. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Trial in Chinese Patients of B-cell Non-Hodgkin's Lymphoma(GB226)
ClinicalTrials.gov study NCT03639181. IPD Sharing: NO. Countries: 1. Publications: 0.
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
ClinicalTrials.gov study NCT03666000. IPD Sharing: NO. Countries: 2. Publications: 0.
Real-world Resource Use and Costs of CAR-T Therapies in Diffuse Large B-cell Lymphoma (DLBCL): Inpatient and Outpatient Settings
ClinicalTrials.gov study NCT05918809. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of ATG-010 in Combination With ATG-008 in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT05354362. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of GNC-038, a Tetra-specific Antibody, in Participants With R/R Diffuse Large B-cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT05192486. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of JNJ-80948543 in Combination With Other CD3 T-Cell Engagers in Participants With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R B-Cell NHL)
ClinicalTrials.gov study NCT06660563. IPD Sharing: YES. Countries: 4. Publications: 0.
JY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell Leukemia
ClinicalTrials.gov study NCT06902025. IPD Sharing: NO. Countries: 1. Publications: 0.
R-BL-M-04 Versus R-(DA)-EPOCH and Autologous Stem Cells Transplantation in Patients With High-Grade B-cell Lymphoma Double-hit (HGBL DH) and High-Grade B-cell Lymphoma Not Otherwise Specified (HGBL NO
ClinicalTrials.gov study NCT03479918. IPD Sharing: NO. Countries: 1. Publications: 0.
Mosunetuzumab Consolidation Therapy After autoSCT in r/r Aggressive B Cell Lymphoma
ClinicalTrials.gov study NCT05412290. IPD Sharing: NO. Countries: 1. Publications: 0.
CD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-ALL.
ClinicalTrials.gov study NCT03671460. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of Loncastuximab Tesirine in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) or High-Grade B-Cell Lymphoma (HGBCL) Following CAR-T Therapy Failure
ClinicalTrials.gov study NCT06918912. IPD Sharing: NO. Countries: 1. Publications: 0.
The Efficacy and Safety of the RCMOP Sequential Therapy as a First-line Treatment for Patients With Intermediate-to-high Risk Diffuse Large B-cell Lymphoma Who Had Incomplete Remission.
ClinicalTrials.gov study NCT05990985. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment of Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT01949818. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.